Provision of Immunization Services

India’s measles-rubella vaccination campaign a big step towards reducing childhood mortality, addressing birth defects

World Health Organization congratulates India for launching one of the world’s largest vaccination campaign against measles, a major childhood killer disease, and congenital rubella syndrome (CRS), responsible for irreversible birth defects.
The campaign launched today to vaccinate more than 35 million children in the age group of nine months to 15 years with MR (measles and rubella) vaccine, once again demonstrates India’s commitment to improve health and well-being of its people by protecting children against vaccine preventable diseases.

Entra en vigor el nuevo calendario de vacunas 2017

¿Cuándo debo vacunar a mi pequeño? Es una pregunta muy común entre los padres. Y más cuando este año el calendario ha variado, una vez más, de forma que el niño tendrá que acudir menos veces y con más diferencia de edad que en calendarios anteriores. Los representantes de salud han asegurado que la efectividad sigue siendo la misma. El calendario ya ha entrado en vigor en las distintas comunidades autónomas.

Haití comenzó campaña de vacunación contra el cólera en zonas más afectadas por huracán Matthew

Les Cayes, Haití, 9 de noviembre de 2016 (OPS/OMS)—Un gran contingente de supervisores nacionales, enfermeras, agentes de salud y crieurs (voceadores a pie) están siendo movilizados por el Ministerio de Salud y de la Población de Haití para vacunar a unas a 800 mil personas que viven en 16 comunas en los departamentos de Sud y Grand’Anse, las áreas más afectadas por el hura


Tchad: lancement d'une campagne de vaccination contre la poliomyélite

Le secrétaire d'Etat tchadien à la Santé publique, Mahamat Annadif Youssouf, a lancé, dimanche à Pala, dans la région du Mayo-Kebbi ouest, frontalière avec le Cameroun, la quatrième édition de la campagne de vaccination contre la poliomyélite.
En réponse aux trois cas de poliovirus sauvage qui ont été confirmés dans l'Etat de Borno, Nigéria, pays frontalier du Tchad, en août 2016, le ministère de la Santé publique, en étroite collaboration avec l'UNICEF et l'OMS, a lancé le 16 septembre une campagne de vaccination en 5 tours.

UNICEF halves price of children’s five-in-one vax with six suppliers

In a deal that could save millions of lives, the United Nations Children’s Fund (UNICEF) has reached an unprecedented agreement with six manufacturers that slashes the price of pentavalent vaccine to half what the agency currently pays.


Seasonal influenza vaccines market will hit $4.3 billion by 2025, says GlobalData

The seasonal influenza vaccine market across the seven major markets (7MM) of the US, France, Germany, Italy, Spain, the UK, and Japan, will rise from $3.1 billion in 2015 to $4.3 billion by 2025, at a compound annual growth rate of 3.3%, according to research and consulting firm GlobalData.


India is next stop for GSK sales and marketing overhaul

GlaxoSmithKline ($GSK) will bring its cleaned-up marketing and sales focus to India by following steps it took in China as it looks to shake off the damage its reputation took with the massive $489 million fine it paid last year for bribing doctors and hospitals to buy its drugs.


Hustling Dollars for Public Health

On Tuesday, a woman infected with the Zika virus gave birth to a girl with microcephaly, a malformed head, in New Jersey. Federal officials say there are more than 300 pregnant women possibly infected with Zika around the country. Yet every time an emergency like this happens, public health officials must go begging bowl in hand to Congress for the funds to deal with it. And as the current squabble between Republicans and President Obama over money for the Zika virus shows, there’s no guarantee of significant or even timely relief.

Inovio Zika vaccine protects monkeys, Senate advances $1.1B Zika funding bill

As the quest for a Zika vaccine unfolds, Inovio Pharma ($INO) continues to lead the pack. The Pennsylvania-based vaccine maker announced Monday that its candidate showed promise in nonhuman primates.

The company’s synthetic DNA vaccine elicited “robust” antibody and T cell responses in monkeys, Inovio said in a statement. Each animal that received two doses of the vaccine developed antibodies against the mosquito-borne disease. Three months ago, Inovio reported that the candidate performed well in mice.